News Search Results
Oct 12, 2025, 20:10 ET Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development
About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Oct 10, 2025, 10:30 ET Single-use Bioprocessing Market worth US$33.67 billion by 2030 with 13.3% CAGR | MarketsandMarkets™.
announcements, including the expansion of its facilities in Germany, China, France, and Ireland, to increase the manufacturing capacity of its biotechnology products. Its expansion activities in Europe and the Asia Pacific in 2024 are further expected to strengthen its position in the single-use bioprocessing
More news about: MarketsandMarkets
Oct 10, 2025, 08:48 ET Development of the First Inner Ear Organoids by 3D Bioprinting for Pharmacological Screening in Hearing Disorders: CTIBIOTECH™ Announces Strategic Agreement With SATT AxLR and CILCARE
About CTIBIOTECH™ CTIBIOTECH™ is a biotechnology company specializing in the development of advanced human tissue models for research, drug discovery and cosmetic testing. Using state-of-the-art
More news about: CTIBIOTECH, CILCARE and SATT AXLR
Oct 10, 2025, 01:12 ET Stockholder Alert: Robbins LLP Informs aTyr Pharma, Inc. Stockholders that a Class Action Lawsuit was Filed Against the Company
purchased or otherwise acquired aTyr Pharma, Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025. aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation.
More news about: Robbins LLP
Oct 09, 2025, 18:56 ET Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
(omalizumab-igec) as well as a novel biologic ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Oct 09, 2025, 17:31 ET Platinum-Resistant Ovarian Cancer Treatment Market Sees Momentum with Next-Generation Targeted Strategies | DelveInsight
Pharmaceutical Co. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Ellipses Pharma, Merck KGaA, Pfizer, Jiangsu HengRui Medicine Co., Ltd., Puma Biotechnology, Inc., Bayer, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daiichi Sankyo, Inc., Astellas Pharma Inc, among others.
More news about: DelveInsight Business Research, LLP
Oct 09, 2025, 14:00 ET WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, has closed the previously announced definitive agreements
More news about: WallachBeth Capital LLC
Oct 09, 2025, 12:35 ET Rubin Rudman Partner Andrea Toulouse Named to Massachusetts Lawyers Weekly's Top Women of Law List
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Oct 09, 2025, 12:17 ET RegCell Scientific Founder and Board Member Dr. Shimon Sakaguchi Awarded Nobel Prize in Physiology or Medicine
EMERYVILLE, Calif., Oct. 9, 2025 /PRNewswire/ -- RegCell, Inc. a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation with its epigenetic reprogramming platform leveraging the
More news about: RegCell, Inc.
Oct 09, 2025, 11:05 ET Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery
Vision Ventures Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology and longevity companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders
More news about: LifeSpan Vision Ventures
Oct 09, 2025, 11:05 ET Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery
Vision Ventures Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology and longevity companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders
More news about: LifeSpan Vision Ventures
Oct 09, 2025, 10:10 ET Wearable Medical Devices Market Poised for USD 499.2 Billion by 2035, Growing at a CAGR 21.6% | Strategic Insights for CXOs and Healthcare Leaders
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Oct 09, 2025, 10:00 ET FYR Integrates CIQ Fuzzball to Scale AI-Enabled Multiomic Platform and Accelerate Breakthroughs in Precision Medicine
FYR, a biotechnology company leveraging extracellular vesicles (EVs) to create an end-to-end solution for new precision medicine tools, has selected Fuzzball, CIQ's
More news about: CIQ
Oct 09, 2025, 09:30 ET Stealth BioTherapeutics Announces Mito Assist™ Patient Support Program and Specialty Pharmacy Partnership with AnovoRx to Distribute FORZINITY™(elamipretide) injection
Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced
More news about: Stealth BioTherapeutics Inc.
Oct 09, 2025, 08:42 ET American Liver Foundation Hosts National Legacy Gala Honoring Leaders in Liver Health
auction and dinner featuring a presentation to our award recipients who have made outstanding contributions to the liver community in the fields of biotechnology, medical innovation, and philanthropy. The 2025 Award Recipients include:
More news about: American Liver Foundation
Oct 09, 2025, 08:30 ET Policy Shifts Reshaping Pharma Strategy: IRA, PBM Reform and Beyond, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 09, 2025, 08:30 ET Can Neuroimaging Save Psychedelic Drug Development? Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 09, 2025, 08:30 ET Pediatric Hematology-Oncology Trials: Successful Novel Therapeutic Strategies, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 09, 2025, 08:30 ET Simplifying CRISPR Therapeutic Manufacturing: Practical Solutions to Accelerate and Simplify Manufacturing, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 09, 2025, 08:04 ET Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in Canada
Intas' biosimilars are manufactured at Intas Pharmaceuticals' state of the art European Union- Good Manufacturing Practices (EU-GMP) certified biotechnology plant located near Ahmedabad, Gujarat. For more information, visit us at
More news about: Bio-Thera Solutions, Ltd
Oct 09, 2025, 07:52 ET Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery in MS Models
next step possible. About Cadenza Bio, Inc. Cadenza Bio, Inc. is a biotechnology company dedicated to developing novel small-molecule drugs for demyelinating and inflammatory diseases. With a mission to break the cycle of disease,
More news about: Cadenza Bio, Inc.
Oct 09, 2025, 07:05 ET REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting
accumulation of fluid in the retina.1 ABOUT REGENXBIO Inc. REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Oct 09, 2025, 07:00 ET Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
sooner". About Adcendo ApS Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts. The company is developing a pipeline of first- and potential
More news about: Adcendo
Oct 09, 2025, 07:00 ET Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma
sooner". About Adcendo ApS Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts. The company is developing a pipeline of first- and potential
More news about: Adcendo
Oct 09, 2025, 07:00 ET Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy
CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ -- Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has closed its previously announced private placement
More news about: Leap Therapeutics, Inc.